🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Carlyle Group Inc. 13F Filings, Portfolio & Analysis

CIK: 0001527166
Washington C/O The Carlyle Group 1001 Pennsylvania Avenue, N.W.
Zip Code: 20004
Latest Portfolio Value
$10.62 B
-21.73%
Total Holdings
20
0
Latest Report Date
Q1 2026
Top 10 Concentration
99.93%

Carlyle Group Inc. — Portfolio Overview & Company Profile

Carlyle Group Inc. (CIK: 0001527166) is a financial institution headquartered at C/O The Carlyle Group, 1001 Pennsylvania Avenue, N.W., Washington, District Of Columbia 20004. The firm regularly files Form 13F with the U.S. Securities and Exchange Commission (SEC), disclosing its equity holdings and investment positions.

As of the latest reporting period (2026-03-31), the institution manages a portfolio valued at $10.62 B, comprising 20 distinct securities. Over its filing history, it has submitted 63 Form 13F reports.

To view the institution’s full SEC filing history:
🔗 View All SEC Filings

Q1 2026 — Top-10 concentration: 99.9%. ▲ 1 new, +0 added, −2 reduced, ×1 exited.

Portfolio Summary (Q1 2026)

Top Buys

Q1 2026
+$497,256

Top Sells

Q1 2026
−$1.76 B
−$1.26 B
−$479,999

Asset Allocation

Stocks/ETFs
-21.73%
$10.62 B 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Top Stock & ETF Holdings (Q1 2026)

Name Shares Market Value Weight Change Activity
187.08 M $8.33 B 78.40% ▼ 28,219,323 Reduce -13.1%
84.59 M $2.18 B 20.58% ▼ 68,086,856 Reduce -44.6%
3.5 M $38.85 M 0.37%
2.36 M $22.3 M 0.21%
664,100 $16.5 M 0.16%
220,500 $8.08 M 0.08%
1.1 M $7.08 M 0.07%
6.23 M $4.95 M 0.05%
Spruce Biosciences
N/A
38,620 $2.52 M 0.02%
107,214 $1.79 M 0.02%

Historical Portfolio Charts